🏭EPA NESHAP for Pharmaceuticals Production Renewal Notice
Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; NESHAP for Pharmaceuticals Production (Renewal)
Summary
The Environmental Protection Agency (EPA) has submitted an information collection request (ICR), NESHAP for Pharmaceuticals Production (EPA ICR Number 1781.10, OMB Control Number 2060-0358) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act. This is a proposed extension of the ICR, which is currently approved through February 28, 2025. Public comments were previously requested via the Federal Register on May 18, 2023 during a 60-day comment period. This notice allows for an additional 30 days for public comments.
Agencies
- Environmental Protection Agency
Business Impact
$$$ - High
The regulatory notice involves the renewal of an information collection request regarding the National Emission Standards for Hazardous Air Pollutants (NESHAP) for pharmaceuticals production, which places compliance requirements on owners of manufacturing operations in this sector. The costs associated (estimated at $5,750,000 annually) and the mandatory nature of reporting indicate significant financial implications for businesses involved.